Studies conflict on aggressive diabetes treatment

02/13/2008 | Reuters

Intensive treatment does not increase the risk of death in Type 2 diabetes patients, according to early results from a large study. The findings contradict the results of a recent U.S. trial that found a slight mortality increase in patients whose blood sugar had been reduced to near-normal ranges. Researchers say the new findings were based on more than twice as much data as the previous study.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA